Group 1 - The core announcement is that Haixiang Pharmaceutical (002099) signed a cooperation agreement with the Hangzhou Advanced Research Institute of the University of Science and Technology of China to establish an Advanced Synthesis Technology Industry Research Institute [1] - The research institute will focus on the development and industrialization of pharmaceutical raw materials, intermediates, dyes, and new materials [1] - The total investment for this collaboration amounts to 50 million RMB [1]

Group 1 - The company, Haishang Pharmaceutical (002099.SZ), has signed a cooperation agreement with the Hangzhou Advanced Research Institute of the University of Science and Technology of China to establish a joint advanced synthetic technology industrial research institute [1] - The research focus of the industrial research institute will primarily be on the development and industrialization of pharmaceutical raw materials, intermediates, dyes, and new materials [1] - The total investment for this collaboration amounts to 50 million yuan [1]

Group 1 - The core viewpoint of the article is that Haishang Pharmaceutical (002099) has signed a cooperation agreement with the Hangzhou Advanced Research Institute of the University of Science and Technology of China to establish an Advanced Synthesis Technology Industry Research Institute, with a total investment of 50 million yuan [1] - The research focus of the new institute will be on the development and industrialization of pharmaceutical raw materials, intermediates, dyes, and new materials [1] - The research team led by Zhang Xiaoheng at the Hangzhou Institute has proposed a new method for the direct deamination of aromatic amines, which is safe and economical, potentially revolutionizing traditional high-risk processes in various fields such as pharmaceuticals, dyes, and materials manufacturing [1]